IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma ; volume:13 ; number:1 ; day:20 ; month:5 ; year:2013 ; pages:1-9 ; date:12.2013
BMC cancer ; 13, Heft 1 (20.5.2013), 1-9, 12.2013
- Urheber
-
Kuijjer, Marieke L.
- Beteiligte Personen und Organisationen
-
Peterse, Elisabeth FP
van den Akker, Brendy EWM
Briaire-de Bruijn, Inge H.
Serra, Massimo
Meza-Zepeda, Leonardo A.
Myklebost, Ola
Hassan, A Bassim
Hogendoorn, Pancras CW
Cleton-Jansen, Anne-Marie
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-13-245
- URN
-
urn:nbn:de:1111-201603049628
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kuijjer, Marieke L.
- Peterse, Elisabeth FP
- van den Akker, Brendy EWM
- Briaire-de Bruijn, Inge H.
- Serra, Massimo
- Meza-Zepeda, Leonardo A.
- Myklebost, Ola
- Hassan, A Bassim
- Hogendoorn, Pancras CW
- Cleton-Jansen, Anne-Marie
- SpringerLink (Online service)
Ähnliche Objekte (12)
Follow-up practices for high-grade extremity Osteosarcoma
Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy
Recurrent Metastatic High-Grade Osteosarcoma: Disease Stabilization and Successful Pregnancy Outcome following Aggressive Multimodality Treatment
A Delta-radiomics model for preoperative evaluation of Neoadjuvant chemotherapy response in high-grade osteosarcoma
Survival benefits and challenges of adjuvant chemotherapy for high-grade osteosarcoma: a population-based study
SOAT1: a suitable target for therapy in high-grade astrocytic glioma?
Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone
Correction: Survival benefits and challenges of adjuvant chemotherapy for high-grade osteosarcoma: a population-based study
mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts
CRISPR-Cas9 knockout screen identifies novel treatment targets in childhood high-grade glioma
Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms
5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma
Follow-up practices for high-grade extremity Osteosarcoma
Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy
Recurrent Metastatic High-Grade Osteosarcoma: Disease Stabilization and Successful Pregnancy Outcome following Aggressive Multimodality Treatment
A Delta-radiomics model for preoperative evaluation of Neoadjuvant chemotherapy response in high-grade osteosarcoma
Survival benefits and challenges of adjuvant chemotherapy for high-grade osteosarcoma: a population-based study
SOAT1: a suitable target for therapy in high-grade astrocytic glioma?
Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone
Correction: Survival benefits and challenges of adjuvant chemotherapy for high-grade osteosarcoma: a population-based study
mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts
CRISPR-Cas9 knockout screen identifies novel treatment targets in childhood high-grade glioma
Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms
5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma
Follow-up practices for high-grade extremity Osteosarcoma
Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy
Recurrent Metastatic High-Grade Osteosarcoma: Disease Stabilization and Successful Pregnancy Outcome following Aggressive Multimodality Treatment
A Delta-radiomics model for preoperative evaluation of Neoadjuvant chemotherapy response in high-grade osteosarcoma
Survival benefits and challenges of adjuvant chemotherapy for high-grade osteosarcoma: a population-based study
SOAT1: a suitable target for therapy in high-grade astrocytic glioma?
Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone
Correction: Survival benefits and challenges of adjuvant chemotherapy for high-grade osteosarcoma: a population-based study
mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts
CRISPR-Cas9 knockout screen identifies novel treatment targets in childhood high-grade glioma
Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms